SEC Form 4 · accession 0001179110-18-010010
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Patrick Guerin
Officer — Chief Financial Officer
Period of report
Jul 26, 2018
Accepted (ET)
Jul 30, 2018 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $0.46 | Jul 26, 2018 | A | 384,950 | A | — | Jul 26, 2028 | Common Stock | 384,950 | 384,950 | D |
Explanation of responses
- F1These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.